Transcatheter tricuspid valve repair
Summary
Tricuspid regurgitation (TR) is a prevalent condition independently associated with increased morbidity and mortality. Despite its prognostic impact, patients with TR are often referred at late disease stages when medical therapy is ineffective and surgical intervention high risk. Transcatheter tricuspid valve repair using the edge-to-edge technique offers a safe and effective alternative for the management of the large population of patients who are ineligible for surgery. While widely available, it remains a technically complex treatment that should be performed at expert centres. Enhancing disease awareness, involvement of multidisciplinary Heart Team and intervening earlier are critical priorities for TR therapies to prevent treatment futility. This chapter highlights recent advances in transcatheter tricuspid valve repair and future directions for addressing significant TR. (Central Illustration)
Central Illustration Download PPTEpidemiology of tricuspid regurgitation
Tricuspid regurgitation (TR) is one of the most common valvular heart diseases. Moderate or greater TR affects approximately 0.55% of the general population, with a higher prevalence in women and the elderly, rising to 21.1% in individuals over 75 years of age 1
Sign up for free!
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com